| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |